Variant report

Variant	rs9636236
Chromosome Location	chr2:127982941-127982942
allele	A/G
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Distal block	Cell Line	Cell type
1	chr2:127976448..127978493-chr2:127980576..127983526,3	MCF-7	breast:
2	chr2:127965809..127968370-chr2:127982231..127984174,2	K562	blood:
3	chr2:127972542..127975941-chr2:127982453..127985678,4	MCF-7	breast:

Variant related genes	Relation type
ENSG00000186684	Chromatin interaction

Extended variants
information (count: 40 )
Associated
traits (count: 0)

rSNPs within LD-proxies of this variant (count:32)

rs_ID	r²[population]
rs10209678	0.82[ASN][1000 genomes]
rs10928761	0.80[AMR][1000 genomes];0.82[ASN][1000 genomes]
rs12463909	0.86[AFR][1000 genomes];0.98[AMR][1000 genomes];0.97[EUR][1000 genomes];0.95[ASN][1000 genomes]
rs12465955	0.84[AMR][1000 genomes];0.95[EUR][1000 genomes]
rs12469035	0.83[AMR][1000 genomes];0.93[EUR][1000 genomes];0.92[ASN][1000 genomes]
rs12623948	0.88[EUR][1000 genomes];0.82[ASN][1000 genomes]
rs12692064	0.82[ASN][1000 genomes]
rs1566822	1.00[AFR][1000 genomes];0.99[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes]
rs2174270	0.83[AMR][1000 genomes];0.95[EUR][1000 genomes]
rs2896888	0.86[AFR][1000 genomes];0.98[AMR][1000 genomes];0.93[EUR][1000 genomes];0.94[ASN][1000 genomes]
rs35328149	0.88[EUR][1000 genomes];0.82[ASN][1000 genomes]
rs3902960	0.94[AFR][1000 genomes];0.97[AMR][1000 genomes];0.99[EUR][1000 genomes];0.99[ASN][1000 genomes]
rs4150407	0.96[CEU][hapmap];0.91[EUR][1000 genomes]
rs4497825	0.81[CEU][hapmap];0.83[EUR][1000 genomes]
rs4560059	0.86[AFR][1000 genomes];0.98[AMR][1000 genomes];0.97[EUR][1000 genomes];0.96[ASN][1000 genomes]
rs4580338	0.98[AFR][1000 genomes];0.98[AMR][1000 genomes];0.96[EUR][1000 genomes];0.98[ASN][1000 genomes]
rs4662710	1.00[CEU][hapmap];1.00[CHB][hapmap];1.00[JPT][hapmap];1.00[YRI][hapmap];0.96[AFR][1000 genomes];0.99[AMR][1000 genomes];0.99[EUR][1000 genomes];0.97[ASN][1000 genomes]
rs4662711	0.88[EUR][1000 genomes];0.84[ASN][1000 genomes]
rs4662712	0.88[EUR][1000 genomes]
rs4662717	0.96[CEU][hapmap];0.93[EUR][1000 genomes]
rs55905117	0.88[EUR][1000 genomes]
rs58475809	0.84[AMR][1000 genomes];0.94[EUR][1000 genomes];0.82[ASN][1000 genomes]
rs6430931	0.88[AMR][1000 genomes];0.92[EUR][1000 genomes];0.93[ASN][1000 genomes]
rs6712213	0.88[EUR][1000 genomes];0.82[ASN][1000 genomes]
rs6712446	0.88[EUR][1000 genomes];0.82[ASN][1000 genomes]
rs6712551	0.88[EUR][1000 genomes];0.82[ASN][1000 genomes]
rs6731176	0.81[CEU][hapmap];0.83[EUR][1000 genomes]
rs71414745	0.83[AMR][1000 genomes];0.90[EUR][1000 genomes];0.81[ASN][1000 genomes]
rs7568261	0.83[EUR][1000 genomes]
rs7585198	0.85[AFR][1000 genomes];0.94[AMR][1000 genomes];0.88[EUR][1000 genomes];0.88[ASN][1000 genomes]
rs7591760	0.96[AMR][1000 genomes];0.90[EUR][1000 genomes];0.89[ASN][1000 genomes]
rs9636235	0.98[AFR][1000 genomes];1.00[AMR][1000 genomes];0.99[EUR][1000 genomes];1.00[ASN][1000 genomes]

Variant overlapped rSNPs/rCNVs (count:8 , 50 per page) page: 1

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	nsv1006112	chr2:127830117-128032546	Transcr. at gene 5' and 3' Enhancers Active TSS Weak transcription Bivalent Enhancer Flanking Active TSS Strong transcription Bivalent/Poised TSS ZNF genes & repeats Flanking Bivalent TSS/Enh Genic enhancers	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	8 gene(s)	inside rSNPs	diseases
2	esv2757832	chr2:127830943-128006514	Enhancers Flanking Bivalent TSS/Enh Weak transcription Active TSS ZNF genes & repeats Bivalent Enhancer Flanking Active TSS Transcr. at gene 5' and 3' Bivalent/Poised TSS Strong transcription Genic enhancers	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	8 gene(s)	inside rSNPs	diseases
3	esv2759090	chr2:127830943-128006514	Flanking Active TSS Enhancers Weak transcription Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Genic enhancers ZNF genes & repeats Bivalent/Poised TSS Strong transcription Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	8 gene(s)	inside rSNPs	diseases
4	nsv1011378	chr2:127841930-128020546	Enhancers Flanking Active TSS ZNF genes & repeats Bivalent Enhancer Weak transcription Active TSS Genic enhancers Flanking Bivalent TSS/Enh Strong transcription Transcr. at gene 5' and 3' Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	8 gene(s)	inside rSNPs	diseases
5	nsv999809	chr2:127841930-128032546	Enhancers Weak transcription Strong transcription Genic enhancers Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS ZNF genes & repeats Bivalent Enhancer Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	8 gene(s)	inside rSNPs	diseases
6	nsv1010669	chr2:127848860-128032546	Active TSS Enhancers Weak transcription Genic enhancers Flanking Active TSS Bivalent/Poised TSS Strong transcription Flanking Bivalent TSS/Enh Bivalent Enhancer ZNF genes & repeats Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	8 gene(s)	inside rSNPs	diseases
7	nsv1003599	chr2:127871183-128059407	Strong transcription Active TSS Enhancers Weak transcription Genic enhancers Bivalent Enhancer Flanking Active TSS Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh ZNF genes & repeats Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	17 gene(s)	inside rSNPs	diseases
8	nsv535920	chr2:127871183-128059407	Flanking Active TSS Weak transcription Enhancers Bivalent Enhancer Active TSS Strong transcription Flanking Bivalent TSS/Enh Genic enhancers Bivalent/Poised TSS Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	17 gene(s)	inside rSNPs	diseases

No data

Chromatin state (count:40 , 50 per page) page: 1

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr2:127978600-127983000	Weak transcription	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
2	chr2:127978600-127983600	Weak transcription	Liver	Liver
3	chr2:127978600-127983800	Weak transcription	Foreskin Melanocyte Primary Cells skin01	Skin
4	chr2:127978800-127983000	Weak transcription	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
5	chr2:127978800-127983200	Weak transcription	NHEK	skin
6	chr2:127978800-127983600	Weak transcription	Foreskin Keratinocyte Primary Cells skin02	Skin
7	chr2:127978800-127983800	Weak transcription	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
8	chr2:127978800-127983800	Weak transcription	HMEC	breast
9	chr2:127979000-127983400	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
10	chr2:127981200-127983600	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
11	chr2:127981200-127983800	Enhancers	Hela-S3	cervix
12	chr2:127981400-127983600	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
13	chr2:127982400-127983000	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
14	chr2:127982400-127983200	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
15	chr2:127982400-127983600	Enhancers	HSMM	muscle
16	chr2:127982400-127984400	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
17	chr2:127982400-127984400	Flanking Active TSS	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
18	chr2:127982400-127985000	Flanking Active TSS	Osteobl	bone
19	chr2:127982600-127983200	Enhancers	ES-WA7 Cell Line	embryonic stem cell
20	chr2:127982600-127983200	Enhancers	HUES64 Cell Line	embryonic stem cell
21	chr2:127982600-127983400	Flanking Active TSS	NH-A	brain
22	chr2:127982600-127983800	Bivalent Enhancer	HepG2	liver
23	chr2:127982600-127984200	Enhancers	ES-I3 Cell Line	embryonic stem cell
24	chr2:127982600-127984200	Flanking Active TSS	A549	lung
25	chr2:127982600-127984400	Enhancers	HUES6 Cell Line	embryonic stem cell
26	chr2:127982600-127984400	Flanking Active TSS	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
27	chr2:127982800-127983000	Bivalent Enhancer	IMR90 fetal lung fibroblasts Cell Line	lung
28	chr2:127982800-127983000	Enhancers	iPS-20b Cell Line	embryonic stem cell
29	chr2:127982800-127983000	Bivalent Enhancer	Brain Cingulate Gyrus	brain
30	chr2:127982800-127983000	Bivalent Enhancer	Fetal Muscle Leg	muscle
31	chr2:127982800-127983000	Bivalent Enhancer	NHLF	lung
32	chr2:127982800-127983200	Bivalent Enhancer	NHDF-Ad	bronchial
33	chr2:127982800-127983400	Bivalent Enhancer	iPS-15b Cell Line	embryonic stem cell
34	chr2:127982800-127983600	Flanking Active TSS	Muscle Satellite Cultured Cells	--
35	chr2:127982800-127983600	Flanking Active TSS	HSMMtube	muscle
36	chr2:127982800-127984000	Bivalent Enhancer	HUVEC	blood vessel
37	chr2:127982800-127984200	Enhancers	Fetal Lung	lung
38	chr2:127982800-127984200	Enhancers	Lung	lung
39	chr2:127982800-127984400	Enhancers	Placenta Amnion	Placenta Amnion
40	chr2:127982800-127984600	Enhancers	Placenta	Placenta

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links